Lexicon Pharmaceuticals | LXRX - Trade Debtors

Stock Price
1.68
Daily Change
-0.03 -1.75%
Monthly
28.24%
Yearly
373.64%
Q1 Forecast
1.66

Lexicon Pharmaceuticals reported $2.62M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Abbott USD 10.4B 166M Sep/2025
Acadia Pharmaceuticals USD 148.23M 8.79M Dec/2025
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
Akebia Therapeutics USD 61.54M 27.17M Mar/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Coherus Biosciences USD 62.44M 59.9M Mar/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Esperion Therapeutics USD 60.36M 5.75M Jun/2024
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
Illumina USD 854M 125M Dec/2025
Insmed USD 140.86M 75.6M Dec/2025
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
J&J USD 17.61B 235M Sep/2025
Lexicon Pharmaceuticals USD 2.62M 1.09M Jun/2024
MacroGenics USD 69.23M 56.7M Sep/2025
MannKind USD 38.37M 20.98M Dec/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 184M 862M Dec/2025
Novartis USD 8.98B 192M Sep/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Thermo Fisher Scientific USD 8.9B 11M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
United Therapeutics USD 350.2M 52.5M Dec/2025
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024